Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIngenta Regulatory News (ING)

Share Price Information for Ingenta (ING)

Share Price is delayed by 15 minutes
Get Live Data
84.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 5.00 (6.098%)
Market Cap: £12.26m
ING Live PriceLast checked at - London Stock Exchange

Intraday Ingenta Share Chart

Director/PDMR Shareholding

22 Nov 2016 09:40

RNS Number : 8205P
Ingenta PLC
22 November 2016
 

22 November 2016

 

Ingenta plc

Directors' Dealings

Ingenta plc (LSE:ING, "Company" or "Ingenta") received notification on 21 November 2016 from Kestrel Partners LLP ("Kestrel") that on 21 November 2016 it acquired, on behalf of its discretionary clients, 25,000 ordinary shares of 10p each ("Shares") in the Company at a price of £1.65 per share. The notification also included the matters set out below.

Kestrel is the investment manager to Kestrel Opportunities, a cell of Guernsey Portfolios PCC Limited ("Kestrel Opportunities"), and various other clients. This disclosure relates to indirect Shares and voting rights in the Company that are managed by Kestrel on a discretionary basis.

Mr. Royde is a partner of, and holds a beneficial interest in Kestrel. Mr. Royde is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Ingenta.

Prior to this purchase of Shares, Kestrel on a combined basis indirectly held Shares and voting rights over 4,398,973 Shares in the Company.

Of the Shares purchased, 21,250 were acquired on behalf of Kestrel Opportunities and following this transaction, Kestrel Opportunities holds (and consequently Mr. Royde is deemed to have a beneficial interest in) 3,338,453 Shares in the Company. The remaining 3,750 Shares were purchased on behalf of Kestrel's other discretionary clients, in which Mr Royde has no beneficial interest, who, following this transaction, hold a further 1,085,520 Shares in the Company.

Following this transaction and on a combined basis, Kestrel indirectly holds voting rights over 4,423,973 Shares in the Company, which represents approximately 26.15% per cent of the Company's issued share capital.

Kestrel's interest in the Shares in the Company is held through the following nominees:

 

Holding type

Nominee

No. of shares

% of issued share capital

Indirect

Bank of New York Nominees Ltd

3,338,453

19.73%

Indirect

JIM Nominees Limited

280,050

1.66%

Indirect

Bank of New York Nominees Ltd

805,470

4.76%

 

 

For further information contact:

Ingenta PlcDavid Montgomery

 

+44 (0) 1865 397 800

Cenkos Securities plcNicholas Wells

Elizabeth Bowman

 

 

+44 (0) 20 7397 8900

 

 

ANNEX

 

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kestrel Partners LLP

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA - Matthew Max Edward Royde (non-executive director Ingenta plc)

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Ingenta plc

b)

 

LEI

 

 

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

10p Ordinary Shares

 

 

ISIN: GB00B3BDTG73

 

b)

 

Nature of the transaction

 

 

Purchase

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

GBP 1.65

 

25,000 Shares

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

Total 25,000 shares @ GBP 1.65

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

2016-11-21

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFMMZMLZLGVZG
Date   Source Headline
18th Nov 20191:53 pmRNSDirector/PDMR Shareholding
14th Nov 20195:06 pmRNSTransaction in Own Shares
28th Oct 20197:00 amRNSContract Wins
17th Oct 20197:00 amRNSDirector/PDMR Shareholding
11th Oct 20197:00 amRNSTransaction in Own Shares
10th Oct 20197:00 amRNSShare Buyback Programme
23rd Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSContract Wins
11th Jun 20197:00 amRNSContract Wins
23rd May 201912:45 pmRNSAGM Statement
23rd Apr 20195:23 pmRNSHolding(s) in Company
18th Apr 20192:30 pmRNSDividend Declaration, Posting of AR&A & AGM Notice
2nd Apr 20194:30 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSFinal Results
6th Feb 20197:00 amRNSDirector/PDMR Shareholding
1st Feb 20197:00 amRNSDirector/PDMR Shareholding
30th Jan 20197:00 amRNSTrading Statement
10th Dec 20187:00 amRNSContract Renewals
31st Oct 20187:00 amRNSAppointment of Director
3rd Oct 201811:00 amRNSAppointment of Director
18th Sep 20187:00 amRNSHalf-year Report
14th Aug 20187:00 amRNSIngenta announces two new multi-year contracts
9th Aug 20187:00 amRNSDirectorate Update
26th Jun 20185:58 pmRNSDirector/PDMR Shareholding
18th Jun 20187:00 amRNSIngenta announces new VAR partnership with ATC
24th May 201812:09 pmRNSAGM Statement & Results of AGM
27th Apr 20187:00 amRNSDividend Declaration, Posting of AR&A & AGM Notice
29th Mar 20187:00 amRNSFinal Results
27th Mar 20183:18 pmRNSCapital Reduction
22nd Feb 20187:00 amRNSSainsbury's sign 3-year agreement with Ingenta
19th Feb 201811:36 amRNSResult of General Meeting
26th Jan 20187:01 amRNSNotice of GM and Proposed Capital Reduction
26th Jan 20187:00 amRNSTrading Update
20th Nov 20177:00 amRNSYewno Appoints PCG to Drive Sales
21st Sep 20173:10 pmRNSGrant of Options
19th Sep 201710:16 amRNSDirector/PDMR Shareholding
18th Sep 201712:21 pmRNSDirector/PDMR Shareholding
13th Sep 20177:00 amRNSInterim Results
15th Aug 20177:00 amRNSContract Win
15th Aug 20177:00 amRNSPre Close Trading Update
19th Jun 201711:41 amRNSDirectorate Disclosure
31st May 20173:50 pmRNSResult of AGM
18th May 20172:36 pmRNSPosting of Annual Report and Accounts
7th Apr 20179:28 amRNSDividend Declaration and notice of AGM
3rd Apr 20177:00 amRNSFinal Results
16th Jan 20177:00 amRNSTrading Update
30th Dec 20162:00 pmRNSDirector/PDMR Shareholding
30th Dec 20161:54 pmRNSDirector/PDMR Shareholding
6th Dec 20165:46 pmRNSDirector/PDMR Shareholding
28th Nov 20167:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.